Clinical factors in association with the complications and the outcome of liver transplantation. The Hungarian experience;A májátültetés szövodményeit és túlélési eredményeit befolyá soló tényezok Magyarországon

Orvosi Hetilap

Volumn 146, Issue 30, 2005, Pages 1567-1574

  Nemes, Balázs ^a,c   Kóbori, László ^a   Gálffy, Zsuzsa ^a   Lengyel, Gabriella ^b   Doros, Attila ^a   Sárváry, Eniko ^a   Perner, Ferenc ^a   Schaff, Zsuzsa ^c   Fazakas, János ^a   Szalay, Ferenc ^d   Fehér, János ^b   Járay, Jeno ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b II Belgyogyaszati Klinika   (Hungary)

^c II Patológiai Intézet ^*  (Hungary)

^d I Belgyogyaszati Klinika   (Hungary)

Author keywords

Hungarian; Liver transplantation; Mortality; Outcome; Sepsis

Indexed keywords

ARTERY THROMBOSIS; ARTICLE; CHI SQUARE TEST; HEALTH CARE POLICY; HUNGARY; KAPLAN MEIER METHOD; KIDNEY FAILURE; LIVER TRANSPLANTATION; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PROPORTIONAL HAZARDS MODEL; RANK SUM TEST; RECEIVER OPERATING CHARACTERISTIC; SEPSIS; STUDENT T TEST; SURVIVAL; TREATMENT OUTCOME; ANALYSIS OF VARIANCE; BILIARY TRACT DISEASE; BLEEDING; COMPARATIVE STUDY; FEMALE; GRAFT REJECTION; HEPATIC ARTERY; HEPATORENAL SYNDROME; HUMAN; MALE; METHODOLOGY; NONPARAMETRIC TEST; PATIENT SELECTION; RETROSPECTIVE STUDY; RISK FACTOR; ROC CURVE; THROMBOSIS;

IMMUNOSUPPRESSIVE AGENT;

ANALYSIS OF VARIANCE; BILIARY TRACT DISEASES; BLOOD LOSS, SURGICAL; FEMALE; GRAFT REJECTION; HEPATIC ARTERY; HEPATORENAL SYNDROME; HUMANS; HUNGARY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE; LIVER TRANSPLANTATION; MALE; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SEPSIS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; THROMBOSIS; TREATMENT OUTCOME;

EID: 25444531496     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Abou El-Ella, K., Al Sebayel, M., Ramirez. C. és mtsai: Outcome and risk factors of hepatic artery thrombosis after orthotopic liver transplantation in adults. Transplant. Proc, 2001, 33, 271-273.
2. Avolio, A. W., Chirico, A. S., Agnes, S. és mtsai: Prediction of 6-months survival after liver transplantation using Cox regression. Transplant. Proc., 2004, 36, 529-532.
3. Bilbao, I., Charco, R., Balsells, J. és mtsai: Risk factors for acute renal failure requiring dialysis after liver transplantation. Clin. Transplant., 1998, 12, 123-129.
4. Bobek I., Járay J., Perner F.: A májátü ltetés anesztéziájának es intenzív terápiájának feltételei. Orv. Hetil. 1996, 137 (42 Suppl. 1), 2375-2377.
5. Calne, R. Y.: A new technique for biliary drainage in orthotopic liver transplantation utilizing the gallbladder as a pedicle graft conduit between the donor and recipient common bile ducts. Ann. Surg., 1976, 184, 605-609.
6. Catalano, G., Urbani, L., Biancofiore, G. és mtsai: Hepatic resection after liver transplantation as a graft saving procedure: indication, criteria, timing and outcome. Transplant. 2004, 36, 545-546.
7. Davison, A. M.: Hepatorenal failure. Nephrol Dial Transplant. 1996, 11 (Suppl. 8.), 24-31.
8. Ferraz-Neto, B. H., Mirza, D. F., Gunson, B. K. és mtsa: Bile duct splintage in liver transplantation: is it necessary? Transpl. Int., 1996, 9 (Suppl. 1.), S185-S187.
9. Fisher, A., Seguel, J. M., de la Torre, A. N.: Effect of sirolimus on infection incidence in liver transplant recipients. Liver Transpl. 2004, 10, 193-198.
10. Forró M, Mándli T.: Folyamatos autotranszfuzió használata májtranszplantáció során. Magy. Seb., 2002, 55, 3-8.
11. Galffy, Z., Jakics, J., Gorog, D. és mtsa: Bacteriological Examination of Liver Transplant Patients. 7th International Congress for Infekcióus Diseases, Hong Kong. 1996. (poster 107.014).
12. Gerle, Z., Galffy, Z., Remport, A. és mtsa: New challenges in liver and kidney transplantation. Mycoses, 2002, 45 (Suppl. 2.), 19.
13. Gondos T., Hernold L., Tóth T. és mtsai: Májtranszplantációs program Magyarországon - az elso 25 eset összegzése aneszteziológus-intenzív terápiás szempontból. Magy. Seb., 1997, 50, 267-275.
14. Görög D., Máthé Zs., Hernold L. és mtsai: Vér és vérkészítmény- felhasználás májátültetés során. Transzfúzió, 1997, 30, 99-108.
15. Hendriks, H. G., Meijer, K., de Wolf, J. T. és mtsai: Reduced transfusion requirements by recombinant factor VIIa in ortothopic liver transplantation: a pilot study. Transplantation, 2001, 71, 402-405.
16. Hendriks, H. G. D., van der Meer, J., de Wolf, J. Th. M. és mtsai: Intraoperative blood transfusion requirement is the main determinant of early surgical reinterventions after orthotopic liver transplantation. Transplant. Int., 2004, 17, 673-679.
17. Hendriks, H. G. D., van der Meer, J., Klompmaker, I. J. és mtsai: Blood loss in orthotopic liver transplantation: a retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients. Blood Coagulation and Fibrinolysis, 2000, 11, S87-S93.
18. Kniepeiss, D., Iberer, F., Grasser, B. és mtsai: A single-center experience with retrograde reperfusion in liver transplantation. Transplant. Int., 2003, 16, 730-735.
19. Kok, T., Slooff, M. J. H., Thijn, C. J. és mtsai: Routine Doppler ultrasound for the detection of clinically unsuspected vascular complications in early postoperative phase after orthotopic liver transplantation. Transpl. Int., 1998, 11, 272-276.
20. Li, G. S., Ye, Q. F., Xia, S. S. és mtsai: Acute respiratory distress syndrome after liver transplantation: etiology, prevention and management. Hepatobiliary Pancreat. Dis. Int., 2002, 1, 330-334.
21. Lima, E. Q., Zanetta, D. M., Castro, I. és mtsai: Risk factors for development of acute renal failure after liver transplantation. Ren Fail., 2003, 25, 553-560.
22. Lin, M., Crawford, M., Fisher, J. és mtsai: Hepatic artery thrombosis and hepatic artery flow rates in aduit orthotopic liver transplantation. ANZ J., Surg. 2002, 72, 789-800.
23. Lutkes, P., Lutz, J., Loock, J. és mtsai: Continuous venovenous hemodialysis treatment in critically ill patients after liver transplantation. Kidney Int. Suppl., 1999, 72, S71-74.
24. Mas, V. R., Fischer, A., Mahif, D. G. és mtsai: Hepatic artery thrombosis after liver transplantation and genetic factors: G20210A polymorphism. Transplantation, 2003, 76, 247-249.
25. Moreno-Gonzalez, E., Meneu-Diaz, J. G., Fundora, Y.: Advantages of the piggy back technique on the intraoperative transfusion, fluid consumption and vasoactive drugs requirements in liver transplantation: a comparative study. Transplant. Proc., 2003, 35, 1918-1919.
26. Nemes, P., Ondrasek, J., Studenik, P. és mtsai: Biliary complications in liver transplantation. Ann. Transplant., 2001, 6, 24-28.
27. Nemes, B., Sárváry, E., Kóbori, L. és mtsai: Serum hepatitis C virus-ribonucleotide acid monitoring after liver transplantation. The Hungarian experience. Dig Liver Dis., 2005, 37, 68-69.
28. Nemes B., Kóbori L., Sárváry E. és mtsai: A hazai májátültetés demográ fiája, perioperatív jellemzoi és mortalitása. Orv. Hetil, 2005, 146, 1423-1432.
29. Northover, J. M. A., Terblanche, J.: A new look at the arterial supply of the bile duet in man and its surgical implications. Br. J. Surg., 1979, 66, 379-385.
30. O'Grady, J. G., Burroughs, A., Hardy, P. és mtsai: Tacrolimus versus micro emulsified cyclosporin in liver transplantation: the TMC randomised controlled trial. Lancet, 2002, 360, 1119-1125.
31. Paramesh, A. S., Roayaie, S., Doan, Y.: Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease. Clin. Transplant., 2004, 18, 94-99.
32. Patkowski, W., Nyckowski, K. és mtsai: Biliary tract complications following liver transplantation. Transplant Proc. 2003, 35, 2316-2317.
33. Perner F.: Májátültetés Magyarországon. Orv. Hetil., 1996, 137 (Suppl. 1.), 2358-2362.
34. Radnai J., Máthé, Zs., Babek I. és mtsai: Transzfúziós problémák májátü ltetés során. Orv. Hetil., 1996, 137 (Suppl. 1.), 2377-2379.
35. Restuccia, T., Ortega, R., Guevara, M. és mtsai: Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. J. Hepatol. 2004, 40, 140-146.
36. Safdar, N., Said, A., Lucey, M. R. és mtsai: Infected bilomas in liver transplant recipients: clinical features, optimal management and risk factors for mortality. Clin. Infect. Dis., 2004, 39, 517-525.
37. Schroeder, R. A., Collins, B. H., Tuttle-Newhatt, E.: Intraoperative fluid management during orthotopic liver transplantation. J. Cardiothorac. Vasc. Anesth., 2004, 18, 438-441.
38. Spanier, T. B., Klein, R. D., Nasraway, S. A. és mtsai: Multiple organ failure after liver transplantation. Crit. Care Med., 1995, 23, 466-473.
39. Stange, B. J., Glanemann, M., Nuessler, N. C. és mtsai: Hepatic artery thrombosis after adult liver transplantation. Liver Transpl., 2003, 9, 612-620.
40. Stogermuller, B., Stark, J., Willschke, H. Z. és mtsai: The effect of hydroxyethyl starch 200 kDa on platelet function. Anest. Analg., 2000, 91, 823-827.
41. Tachopoulou O. A., Vogt, D. P., Henderson, J. M.: Hepatic abscess after liver transplantation: 1990-2000. Transplantation, 2003, 75, 79-83.
42. Urbani, L., Catalano, G., Biancofiore, G. és mtsai: Surgical complications after liver transplantation. Minerva Chir., 2003, 58, 675-692.
43. Vivarelli, M., Cucchetti, A., La Barba, G. és mtsai: Ischemic arterial complications after liver transplantation in the adult: multivariate analizis of risk factors. Arch., Surg., 2004, 139, 1069-1074.
44. Weszelits V., Dabasi G., Puhl M. és mtsai: A májtranszplantáció posztoperatív szakasza a radiológus szcmszögébol Magy. Seb., 1997, 50, 303-306.
45. Wright, M., Goldin, R., Hellier, S. és mtsai: Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infekción. Gut, 2003, 52, 1206-1210.
46. Zhou, G. W., Cai, W. Y., Li, H. W. és mtsai: Transjugular intrahepatic portosystemic shunt for liver transplantation. Hepatobiliary Pancreat Dis. Int., 2002, 1, 179-182.
47. Zweig. M. H., Campbell, G.: Receiver operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clinical Chemistry, 1993, 39, 561-577.